Uploaded August 2026 | Updated November 2026, 3 days ago
Most men who start testosterone never needed it, and some who genuinely do never get treated. In the final episode of the Signal series, Dr. Jordan Feigenbaum and Dr. Austin Baraki work through who actually needs testosterone replacement, who got sold it, and what the evidence says about the risks that scared the field for a decade. We cover the blinded trial where men couldn't tell real testosterone from placebo, what the heart and prostate data actually show now that we have the trials, what testosterone does to fertility, and the framework we use to decide. We also close the story of Mark, the patient whose lab result started the series.
This is educational content, not medical advice. Talk to your physician about your personal situation.
Here we cover the real diagnosis of testosterone deficiency, primary versus secondary low testosterone, how the system both over- and under-prescribes, the SHBG trap that makes a normal level look low, the gray-zone crossover study, what replacement should actually target, why most men quit within a year, testosterone as a male contraceptive, the TRAVERSE cardiovascular results, the saturation model and prostate safety, the blood side effect worth monitoring, and when not to start at all.
Timestamps:
• 00:00 The study almost nobody mentions
• 01:31 Who this episode is for
• 03:35 What a real testosterone diagnosis requires
• 07:18 Primary vs secondary low testosterone
• 10:12 How testosterone gets over-prescribed
• 11:35 The SHBG trap: when a low number misleads
• 18:10 Would GLP-1 plus testosterone work better?
• 22:19 Why genuine deficiency gets under-treated
• 24:15 The cardiovascular scare and where it came from
• 34:11 The gray-zone study, in full
• 41:02 What TRT should actually target, and the "900" myth
• 47:38 Running TRT as a trial, and why 70% quit
• 52:36 Testosterone as a contraceptive: the fertility cost
• 57:19 Does TRT cause heart problems? The TRAVERSE trial
• 01:01:40 Testosterone and the prostate
• 01:09:13 The blood side effect worth watching
• 01:12:02 When not to start testosterone
• 01:14:26 Who actually benefits from TRT
• 01:18:28 The Signal framework, and what happened to Mark
• 01:21:14 Five things to take away
• 01:23:33 Our conflict of interest, and the book
•
Resources:
Buy the book, Signal: barbellmedicine.com/shop/learning/signal
• Part 1: Is the testosterone crisis real? (redcircle.com/shows/0cc66fc4-ccb8-4c60-8cc6-7367e52c4159/ep/b25a8006-57e5-4dc3-b74c-203f6fbcebc1)
• Part 2: Is you testosterone actually low? (redcircle.com/shows/0cc66fc4-ccb8-4c60-8cc6-7367e52c4159/ep/b25a8006-57e5-4dc3-b74c-203f6fbcebc1)
• Part 3: What's actually driving your testosterone down? (redcircle.com/shows/0cc66fc4-ccb8-4c60-8cc6-7367e52c4159/ep/c9fdd6b7-3281-4904-b612-1b9d5383efb6)
New Barbell Medicine Hybrid 5K and 10K Run + Lift Programs (barbellmedicine.com/shop/training-templates/endurance/hybrid-5k-10k/)
Barbell Medicine coaching and templates: barbellmedicine.com
Testosterone Action Plan: barbellmedicine.com/testosterone-action-plan/
1. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762-769. doi:10.1111/j.1742-1241.2006.00992.x
2. Baillargeon J, Urban RJ, Ottenbacher KJ, Pierson KS, Goodwin JS. Trends in androgen prescribing in the United States, 2001-2011. JAMA Intern Med. 2013;173(15):1465-1466. doi:10.1001/jamainternmed.2013.6895
3. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. doi:10.1210/jc.2018-00229
4. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. doi:10.1016/j.juro.2018.03.115
5. Corona G, Goulis DG, Huhtaniemi I, et al. European Academy of Andrology (EAA) and European Society of Endocrinology (ESE) recommendations on the diagnosis and management of male hypogonadism. Andrology. 2020;8(5):970-987. doi:10.1111/andr.12770
6. Morgentaler A, Zitzmann M, Traish AM, et al. Commentary: who is a candidate for testosterone therapy? A synthesis of international expert opinions. J Sex Med. 2014;11(7):1636-1645. doi:10.1111/jsm.12546
7. Mok SF, Fennell C, Savkovic S, et al. Testosterone for androgen deficiency-like symptoms in men without pathologic hypogonadism: a randomized, placebo-controlled cross-over with masked choice extension clinical trial. J Gerontol A Biol Sci Med Sci. 2020;75(9):1723-1731. doi:10.1093/gerona/glz195
8. Clift AK, Johnson H, Huang DR, Morgentaler A. Real-world outcomes and safety of testosterone therapy: a longitudinal, retrospective cohort ...
Most men who start testosterone never needed it, and some who genuinely do never get treated. In the final episode of the Signal series, Dr. Jordan Feigenbaum and Dr. Austin Baraki work through who actually needs testosterone replacement, who got sold it, and what the evidence says about the risks that scared the field for a decade. We cover the blinded trial where men couldn't tell real testosterone from placebo, what the heart and prostate data actually show now that we have the trials, what testosterone does to fertility, and the framework we use to decide. We also close the story of Mark, the patient whose lab result started the series.
This is educational content, not medical advice. Talk to your physician about your personal situation.
Here we cover the real diagnosis of testosterone deficiency, primary versus secondary low testosterone, how the system both over- and under-prescribes, the SHBG trap that makes a normal level look low, the gray-zone crossover study, what replacement should actually target, why most men quit within a year, testosterone as a male contraceptive, the TRAVERSE cardiovascular results, the saturation model and prostate safety, the blood side effect worth monitoring, and when not to start at all.
Timestamps:
• 00:00 The study almost nobody mentions
• 01:31 Who this episode is for
• 03:35 What a real testosterone diagnosis requires
• 07:18 Primary vs secondary low testosterone
• 10:12 How testosterone gets over-prescribed
• 11:35 The SHBG trap: when a low number misleads
• 18:10 Would GLP-1 plus testosterone work better?
• 22:19 Why genuine deficiency gets under-treated
• 24:15 The cardiovascular scare and where it came from
• 34:11 The gray-zone study, in full
• 41:02 What TRT should actually target, and the "900" myth
• 47:38 Running TRT as a trial, and why 70% quit
• 52:36 Testosterone as a contraceptive: the fertility cost
• 57:19 Does TRT cause heart problems? The TRAVERSE trial
• 01:01:40 Testosterone and the prostate
• 01:09:13 The blood side effect worth watching
• 01:12:02 When not to start testosterone
• 01:14:26 Who actually benefits from TRT
• 01:18:28 The Signal framework, and what happened to Mark
• 01:21:14 Five things to take away
• 01:23:33 Our conflict of interest, and the book
•
Resources:
Buy the book, Signal: barbellmedicine.com/shop/learning/signal
• Part 1: Is the testosterone crisis real? (redcircle.com/shows/0cc66fc4-ccb8-4c60-8cc6-7367e52c4159/ep/b25a8006-57e5-4dc3-b74c-203f6fbcebc1)
• Part 2: Is you testosterone actually low? (redcircle.com/shows/0cc66fc4-ccb8-4c60-8cc6-7367e52c4159/ep/b25a8006-57e5-4dc3-b74c-203f6fbcebc1)
• Part 3: What's actually driving your testosterone down? (redcircle.com/shows/0cc66fc4-ccb8-4c60-8cc6-7367e52c4159/ep/c9fdd6b7-3281-4904-b612-1b9d5383efb6)
New Barbell Medicine Hybrid 5K and 10K Run + Lift Programs (barbellmedicine.com/shop/training-templates/endurance/hybrid-5k-10k/)
Barbell Medicine coaching and templates: barbellmedicine.com
Testosterone Action Plan: barbellmedicine.com/testosterone-action-plan/
1. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762-769. doi:10.1111/j.1742-1241.2006.00992.x
2. Baillargeon J, Urban RJ, Ottenbacher KJ, Pierson KS, Goodwin JS. Trends in androgen prescribing in the United States, 2001-2011. JAMA Intern Med. 2013;173(15):1465-1466. doi:10.1001/jamainternmed.2013.6895
3. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. doi:10.1210/jc.2018-00229
4. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. doi:10.1016/j.juro.2018.03.115
5. Corona G, Goulis DG, Huhtaniemi I, et al. European Academy of Andrology (EAA) and European Society of Endocrinology (ESE) recommendations on the diagnosis and management of male hypogonadism. Andrology. 2020;8(5):970-987. doi:10.1111/andr.12770
6. Morgentaler A, Zitzmann M, Traish AM, et al. Commentary: who is a candidate for testosterone therapy? A synthesis of international expert opinions. J Sex Med. 2014;11(7):1636-1645. doi:10.1111/jsm.12546
7. Mok SF, Fennell C, Savkovic S, et al. Testosterone for androgen deficiency-like symptoms in men without pathologic hypogonadism: a randomized, placebo-controlled cross-over with masked choice extension clinical trial. J Gerontol A Biol Sci Med Sci. 2020;75(9):1723-1731. doi:10.1093/gerona/glz195
8. Clift AK, Johnson H, Huang DR, Morgentaler A. Real-world outcomes and safety of testosterone therapy: a longitudinal, retrospective cohort ...
![Where did the advice to not lift heavy weights come from?
Nearly every warning youve heard about lifting weights was written down before anybody checked it. We trace where those warnings came from, starting with a Harvard student in 1854 and ending with a curve on a graph thats being used today to argue you can lift too much.
Along the way: the men who built themselves with barbells and then sold the public five-pound dumbbells, because iron was expensive to mail and a booklet cost pennies. The muscle-bound myth, which nobody could define when a graduate student surveyed 45 physiologists about it. The 1961 report that took the deep squat out of every branch of the American military, measured with a device its author built himself and never validated. The claim that lifting stunts a childs growth, which no professional body ever actually made. And the argument women got, which was never about injury at all.
Timestamps:
• 0:00 Intro
• 2:33 2,500 years of people picking up heavy things
• 7:24 George Windship and the Health Lift
• 10:56 Blaikies truck horse and the muscle-bound myth
• 14:59 Bernarr Macfadden
• 19:39 Charles Atlas and Dynamic Tension
• 27:01 Carl Klein, a homemade device, and the parallel squat
• 30:57 Thomas Delorme and three sets of ten
• 35:20 Kids, growth plates, and where the stunting idea came from
• 41:43 Women, youll get bulky, and Dudley Sargent in 1912
• 50:05 Pregnancy, from 1949 to a 2025 barbell study
• 53:40 The pattern, and the curve on next weeks graph
Resources:
Buy the book, Signal: https://www.barbellmedicine.com/shop/learning/signal/
New Barbell Medicine Hybrid 5K and 10K Run + Lift Programs (https://www.barbellmedicine.com/shop/training-templates/endurance/hybrid-5k-10k/)
Barbell Medicine coaching and templates: https://www.barbellmedicine.com
1. Downs DS, Chasan-Taber L, Evenson KR, Leiferman J, Yeo S. Physical activity and pregnancy: past and present evidence and future recommendations. Res Q Exerc Sport. 2012;83(4):485-502. doi:10.1080/02701367.2012.10599138. PMID 23367811.
2. McMurray RG, Mottola MF, Wolfe LA, Artal R, Millar L, Pivarnik JM. Recent advances in understanding maternal and fetal responses to exercise. Med Sci Sports Exerc. 1993;25(12):1305-1321. PMID 8107536.
3. Smith KM, Campbell CG. Physical activity during pregnancy: impact of applying different physical activity guidelines. J Pregnancy. 2013;2013:165617. doi:10.1155/2013/165617. PMID 23476778.
4. American College of Obstetricians and Gynecologists. Physical activity and exercise during pregnancy and the postpartum period. ACOG Committee Opinion No. 804. Obstet Gynecol. 2020;135(4):e178-e188. doi:10.1097/AOG.0000000000003772. PMID 32217980.
5. American Academy of Pediatrics Committee on Sports Medicine and Fitness. Strength training by children and adolescents. Pediatrics. 2001;107(6):1470-1472. doi:10.1542/peds.107.6.1470. PMID 11389279.
6. Stricker PR, Faigenbaum AD, McCambridge TM; Council on Sports Medicine and Fitness. Resistance training for children and adolescents. Pediatrics. 2020;145(6):e20201011. doi:10.1542/peds.2020-1011. PMID 32457216.
7. Gardiner EN. Athletics of the Ancient World. Clarendon Press; 1930:54. See also Gardiner EN. Olympia: Its History and Remains. Clarendon Press; 1925.
8. Heffernan C. The Bybon stone and ancient strength. Physical Culture Study. 2021. Accessed September 2026. https://physicalculturestudy.com.
9. Pausanias. Description of Greece. 6.14.5. Jones WHS, trans. Loeb Classical Library. Harvard University Press.
10. Quintilian. Institutio Oratoria. 1.9.5. Butler HE, trans. Loeb Classical Library. Harvard University Press.
11. Heffernan C. Milo of Croton and the invention of progressive overload. Physical Culture Study. 2026. Accessed September 2026. https://physicalculturestudy.com. See also H.J. Lutcher Stark Center for Physical Culture and Sports, University of Texas at Austin, Milo Bar-Bell Company holdings.
12. Liddell HG, Scott R. A Greek-English Lexicon. 9th ed. Clarendon Press; entry γυμνάσιον. Thucydides. History of the Peloponnesian War. 1.6. Crawley R, trans.
13. Tomlinson RA. Gymnasium. In: Oxford Classical Dictionary. Oxford University Press; 2015. doi:10.1093/acrefore/9780199381135.013.2963. See also Stavrou D. The Greek Gymnasium [thesis]. University of Leicester; 2016:38.
14. Xenophon. Constitution of the Lacedaimonians. 1.4. Marchant EC, trans. Loeb Classical Library. Harvard University Press.
15. Plutarch. Life of Lycurgus. 14. Perrin B, trans. Loeb Classical Library. Harvard University Press.
16. Ollier F. Le Mirage Spartiate. Vols 1-2. Boccard; 1933-1943. Discussed in Rahe PA. The Grand Strategy of Classical Sparta. Yale University Press; 2016. See also Christesen P. Utopia on the Eurotas: Economic Aspects of the Spartan Mirage. In: Powell A, Hodkinson S, eds. Sparta: The Body Politic. Classical Press of Wales; 2010.
17. Pausania... Where did the advice to not lift heavy weights come from?](https://i.ytimg.com/vi/l9qk8SsQYh0/mqdefault.jpg)









